GSA Capital Partners’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-67,143
| Closed | -$1.34M | – | 1801 |
|
|
2025
Q1 | $1.34M | Sell |
67,143
-3,658
| -5% | -$73.2K | 0.12% | 210 |
|
|
2024
Q4 | $1.89M | Buy |
70,801
+18,974
| +37% | +$506K | 0.14% | 97 |
|
|
2024
Q3 | $1.48M | Buy |
+51,827
| New | +$1.48M | 0.11% | 226 |
|
|
2024
Q2 | – | Sell |
-52,448
| Closed | -$1.16M | – | 1687 |
|
|
2024
Q1 | $1.16M | Buy |
52,448
+4,352
| +9% | +$96.4K | 0.09% | 349 |
|
|
2023
Q4 | $1.04M | Sell |
48,096
-4,099
| -8% | -$88.5K | 0.09% | 372 |
|
|
2023
Q3 | $882K | Buy |
52,195
+11,280
| +28% | +$191K | 0.08% | 470 |
|
|
2023
Q2 | $561K | Buy |
40,915
+8,626
| +27% | +$118K | 0.06% | 671 |
|
|
2023
Q1 | $734K | Buy |
32,289
+5,393
| +20% | +$123K | 0.07% | 485 |
|
|
2022
Q4 | $633K | Sell |
26,896
-38,353
| -59% | -$903K | 0.08% | 452 |
|
|
2022
Q3 | $1.7M | Buy |
+65,249
| New | +$1.7M | 0.23% | 34 |
|